Literature DB >> 8793091

Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms.

C F de Mello1, J Begnini, R E Jiménez-Bernal, M A Rubin, J de Bastiani, E da Costa, M Wajner.   

Abstract

The effect of intrastriatal administration of methylmalonic acid (MMA), a metabolite that accumulates in methylmalonic aciduria, on behavior of adult male Wistar rats was investigated. After cannula placing, rats received unilateral intrastriatal injections of MMA (buffered to pH 7.4 with NaOH) or NaCl. MMA induced rotational behavior toward the contralateral side of injection and clonic convulsions in a dose-dependent manner. Rotational behavior and convulsions were prevented by intrastriatal preadministration of MK-801 and attenuated by preadministration of succinate. This study provides evidence for a participation of NMDA receptors in the MMA-induced behavioral alterations, where succinate dehydrogenase inhibition seems to have a pivotal role.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8793091     DOI: 10.1016/0006-8993(96)00117-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

Review 1.  Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia.

Authors:  Daniela R Melo; Alicia J Kowaltowski; Moacir Wajner; Roger F Castilho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

Review 2.  The importance of methylmalonic acid dosage on the assessment of patients with neurological manifestations following bariatric surgery.

Authors:  Camilo Vieira; Camila Cosmo; Rita Lucena
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

3.  Experimental evidence that methylmalonic acid provokes oxidative damage and compromises antioxidant defenses in nerve terminal and striatum of young rats.

Authors:  Carolina Gonçalves Fernandes; Clarissa Günther Borges; Bianca Seminotti; Alexandre Umpierrez Amaral; Lisiane Aurélio Knebel; Paula Eichler; Anderson Büker de Oliveira; Guilhian Leipnitz; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.046

4.  Animal models for glutaryl-CoA dehydrogenase deficiency.

Authors:  D M Koeller; S Sauer; M Wajner; C F de Mello; S I Goodman; M Woontner; C Mühlhausen; J G Okun; S Kölker
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 5.  Neurological dysfunction in methylmalonic acidaemia is probably related to the inhibitory effect of methylmalonate on brain energy production.

Authors:  M Wajner; J C Coelho
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

6.  Neurological outcome of methylmalonic acidaemia.

Authors:  P Nicolaides; J Leonard; R Surtees
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

7.  Intrastriatal malonate administration induces convulsive behaviour in rats.

Authors:  J Fleck; M C P Ribeiro; C M Schneider; V D G Sinhorin; M A Rubin; C F Mello
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 8.  The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.

Authors:  M Wajner; A Latini; A T S Wyse; C S Dutra-Filho
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 9.  Neurodegeneration and chronic renal failure in methylmalonic aciduria--a pathophysiological approach.

Authors:  M A Morath; J G Okun; I B Müller; S W Sauer; F Hörster; G F Hoffmann; S Kölker
Journal:  J Inherit Metab Dis       Date:  2007-09-12       Impact factor: 4.982

10.  Perioperative characteristics and management of liver transplantation for isolated methylmalonic acidemia-the largest experience in China.

Authors:  Yi-Zhou Jiang; Li-Ying Sun; Zhi-Jun Zhu; Lin Wei; Wei Qu; Zhi-Gui Zeng; Ying Liu; Yu-Le Tan; En-Hui He; Rui-Fang Xu; Liang Zhang; Jun Wang; Xiao-Jie Chen
Journal:  Hepatobiliary Surg Nutr       Date:  2019-10       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.